Blood Targets of Adjuvant Drugs Against COVID19

While waiting for the vaccine and/or the best treatment for COVID19, several drugs have been identified as potential adjuvant drugs to counteract the viral action. Several drugs, in fact, have been suggested for their ancillary antiviral role. Viral proteases and peptidases, may interact with well-k...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Blood Med
Autores principales: Di Micco, Pierpaolo, Di Micco, Gianluca, Russo, Vincenzo, Poggiano, Maria Rita, Salzano, Ciro, Bosevski, Marijan, Imparato, Michele, Fontanella, Luca, Fontanella, Andrea
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2020
Materias:
Expert Opinion
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7338832/
https://ncbi.nlm.nih.gov/pubmed/32694923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S256121
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares